J Gen Virol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Borrego, B.
Right arrow Articles by Brocchi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Borrego, B.
Right arrow Articles by Brocchi, E.
Agricola
Right arrow Articles by Borrego, B.
Right arrow Articles by Brocchi, E.
Journal of General Virology (2002), 83, 35-44.
© 2002 Society for General Microbiology


Animal: RNA Viruses

Characterization of neutralization sites on the circulating variant of swine vesicular disease virus (SVDV): a new site is shared by SVDV and the related coxsackie B5 virus

Belén Borrego1, Elena Carra1, Juan Antonio García-Ranea2 and Emiliana Brocchi1

Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna ‘Bruno Ubertini’, Via A. Bianchi 9, 25124 Brescia, Italy1
Protein Design Group, Centro Nacional de Biotecnología, Cantoblanco, 28049 Madrid, Spain2

Author for correspondence: Emiliana Brocchi. Fax +39 030 2290 310. e-mail EBrocchi{at}bs.izs.it

Using a panel of new monoclonal antibodies (mAbs), five neutralizing, conformation-dependent sites have been identified on the antigenic variant of swine vesicular disease virus (SVDV) circulating currently. In studies on the antigenic conservation of these sites, the four antigenic/genetic groups of SVDV described showed distinguishable patterns, confirming this classification. By sequencing mAb-resistant mutants, the five sites have been mapped precisely and localized on a three-dimensional model of the SVDV capsid. All were found to be orientated, to a different extent, towards the external surface of the capsid. Three of the five sites, located in VP1, VP2 and VP3, correspond to epitopes identified previously in historic isolates as sites 1, 2a and 3b, respectively. Another site, site IV, which maps to position 258 of VP1, corresponds to an epitope reported recently and is described in this study to be specific for isolates of the most recent antigenic group of SVDV. A fifth site is described for the first time and corresponds to the unique neutralizing site that is common to both SVDV and coxsackie B5 virus; it maps to positions 95 and 98 of VP1, but may also include positions nearby that belong to site 1 on the BC-loop of VP1, suggesting the classification of site Ia. These results may have useful diagnostic and epidemiological applications, since mAbs to the new conserved site Ia provide universal reagents for SVDV detection systems, while the specificity of mAbs to site IV make them unique markers for the most recent strains of SVDV.




This article has been cited by other articles:


Home page
J. Virol.Home page
M. A. Martin-Acebes, M. Gonzalez-Magaldi, A. Vazquez-Calvo, R. Armas-Portela, and F. Sobrino
Internalization of Swine Vesicular Disease Virus into Cultured Cells: a Comparative Study with Foot-and-Mouth Disease Virus
J. Virol., May 1, 2009; 83(9): 4216 - 4226.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S.-Q. Sun, X.-T. Liu, H.-C. Guo, S.-H. Yin, Y.-J. Shang, X. Feng, Z.-X. Liu, and Q.-G. Xie
Protective immune responses in guinea pigs and swine induced by a suicidal DNA vaccine of the capsid gene of swine vesicular disease virus
J. Gen. Virol., March 1, 2007; 88(3): 842 - 848.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y.-J. Ko, K.-S. Choi, J.-J. Nah, D. J. Paton, J.-K. Oem, G. Wilsden, S.-Y. Kang, N.-I. Jo, J.-H. Lee, J.-H. Kim, et al.
Noninfectious Virus-Like Particle Antigen for Detection of Swine Vesicular Disease Virus Antibodies in Pigs by Enzyme-Linked Immunosorbent Assay
Clin. Vaccine Immunol., August 1, 2005; 12(8): 922 - 929.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. A. Jimenez-Clavero, E. Escribano-Romero, V. Ley, and O. B. Spiller
More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55)
J. Gen. Virol., May 1, 2005; 86(5): 1369 - 1377.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
E. Escribano-Romero, M. A. Jimenez-Clavero, P. Gomes, J. A. Garcia-Ranea, and V. Ley
Heparan sulphate mediates swine vesicular disease virus attachment to the host cell
J. Gen. Virol., March 1, 2004; 85(3): 653 - 663.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Verdaguer, M. A. Jimenez-Clavero, I. Fita, and V. Ley
Structure of Swine Vesicular Disease Virus: Mapping of Changes Occurring during Adaptation of Human Coxsackie B5 Virus To Infect Swine
J. Virol., September 15, 2003; 77(18): 9780 - 9789.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Borrego, J. A. Garcia-Ranea, A. Douglas, and E. Brocchi
Mapping of linear epitopes on the capsid proteins of swine vesicular disease virus using monoclonal antibodies
J. Gen. Virol., June 1, 2002; 83(6): 1387 - 1395.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2002 by the Society for General Microbiology.